AbbVie Inc

Entasis Therapeutics Inc, based in Waltham, MA, is a leading biopharmaceutical company focused on developing and delivering innovative therapies for patients in critical care and infectious disease. With a global mission to address urgent needs and advance treatment options in areas of high unmet need, they offer innovative solutions for patients with serious, life-threatening conditions and therapies for emerging illnesses caused by drug-resistant microorganisms. As a subsidiary of Innoviva, Inc, Entasis Therapeutics Inc is a growing and diversified company that blends rigorous medical science with the latest advances in pharmaceutical innovation. Led by a mission-driven team, they are dedicated to delivering products that save lives and making a lasting impact in the field of healthcare.Generated from the website

Parexel MMS is a leading global contract research organization (CRO) dedicated to accelerating the development of life-changing medicines by engaging patients throughout the drug development process. With a comprehensive range of capabilities, the company offers end-to-end solutions including portfolio optimization, regulatory strategy, and clinical trial management across various therapeutic areas. Focused on operational excellence and innovation, Parexel MMS employs integrated evidence generation and advanced methodologies to support clients in achieving successful market access for their therapies. The firm's commitment to patient-centric approaches is further exemplified by its collaboration with trial sites and advocacy groups to enhance patient participation in clinical research. Generated from the website

Alkermes is a worldwide pharmaceutical company that develops controlled, sustained-release injectable drugs using with its trademark ProLease and Medisorb technologies. Located in Massachusetts, the company also develops inhaled formulations from its proprietary pulmonary technology. Alkermes has partnered with Johnson & Johnson to develop Riserpdal Consta, an antipsychotic drug used in the treatment of schizophrenia. Risperdal Consta is approved for sale in more than 50 countries that include the United States, United Kingdom and Germany. In addition to a host of partnered products, the ocmpany is also active in the development of several promising proprietary products, such as Vivitrex, a long-acting injectable form of naltrexone for alcohol dependence. Alkermes is headquartered in Cambridge, Mass.